
Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. (EIKN)
WebsitePrice
Market cap
Next catalystExpected 2H 2026EIK1004 — EIK1004-001 monotherapy · Dosing completionCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved